Myrcene exerts anti-asthmatic activity in neonatal rats via modulating the matrix remodeling

• Published in: International journal of immunopathology and pharmacology Vol. 34; pp. 205873842095494 - 2058738420954948
• Main Authors: Du, Yanhui, Luan, Jie, Jiang, Ren Peng, Liu, Juan, Ma, Yan
• Format: Journal Article
• Language: English
• Published: London, England SAGE Publications 2020; Sage Publications Ltd
• Subjects: Alveoli; Analgesics; Antioxidants; Asthma; CD14 antigen; Extracellular matrix; Immunoglobulin E; Inflammation; Interleukin 18; Interleukin 2; Interleukin 21; Interleukin 4; Matrix protein; Monocyte chemoattractant protein 1; Myrcene; Neonates; Original; anti-asthmatic activity; myrcene; matrix remodeling; neonatal rats
• ISSN: 2058-7384; 0394-6320; 2058-7384
• DOI: 10.1177/2058738420954948

Myrcene (MC), an organic hydrocarbon, was found to exert anti-inflammatory, analgesic, antimutagenic and antioxidant properties. However, the protective role of MC has not been reported against neonatal asthma. Wistar rats induced with asthma were administered with MC; while asthma control and vehicle control were maintained without MC administration. At the end of the experimental period, lung histology, inflammatory cell counts, cytokine analysis, matrix protein expressions were elucidated. Rats administered with MC exerted significant (P < 0.05) defense in protecting the lung tissue with the evidenced restoration of alveolar thickening of the lung tissues. Also, the present study elicited the anti-asthmatic activity of MC, especially via modulating the extracellular matrix protein expression in the asthma-induced animals, while a significant reduction (P < 0.05) in the fibrotic markers were found in MC treated animals. Moreover, the protective effect of MC was evidenced with reduced leukocyte infiltration in BALF, hypersensitive specific IgE levels with a profound decrease in the inflammatory cytokines such as IL-2, IL-4, IL-18, and IL-21 in MC administered animals compared to the asthma-induced group. To an extent, the markers of asthmatic inflammation such as CD14, MCP-1, and TARC were also found to be attenuated in MC exposed animals. The possible application of MC is a promising drug for the treatment of asthma-mediated complications.